Market Introduction
Anticoagulant reversal drugs are required to reverse the effect of anticoagulation in certain situations such as unplanned surgery, overdose of anticoagulant therapy, and uncontrolled bleeding. In medical conditions such as venous thromboembolism, atrial fibrillation (AF), mechanical valve replacement, and other coagulation disorders such as antiphospholipid antibody syndrome, Factor V Leiden, anticoagulant reversal drugs are used.
Thus, the increasing prevalence of stroke is expected to create a significant demand for anticoagulant reversal drugs in the coming years, which is further anticipated to drive the anticoagulant reversal drug market.
Market Overview and Dynamics
The anticoagulant reversal drug market in South and Central America is expected to grow from US$ 29.8 million in 2019 to US$ 63.1 million by 2027; it is estimated to grow at a CAGR of 10.5% from 2019 to 2027. Various players operating in anticoagulant reversal drugs market are developing and launching new products to expand their geographic reach and capacity to cater a large number of customers. In April 2018, Boehringer Ingelheim, a leading pharmaceutical company, received the US Food and Drug Administration (FDA) full approval for Praxbind (idarucizumab), the specific reversal agent for Pradaxa (dabigatran etexilate mesylate). Similarly, in May 2018, Portola Pharmaceuticals received FDA approval for the rapid reversal of anticoagulation due to major bleeding. Such developments and approvals of new products are likely to favor the market growth.
Key Market Segments
In terms of product, the prothrombin complex concentrates segment accounted for the largest share of the South and Central America anticoagulant reversal drug market in 2019. In terms of distribution channel, the hospital pharmacies segment held a larger market share of the anticoagulant reversal drug market in 2019.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the anticoagulant reversal drug market in South and Central America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Boehringer Ingelheim International GmbH, Pfizer Inc, Octapharma AG, Fresenius Kabi AG, Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals), CSL Limited, and Grifols, S.A.
Reasons to buy report
SOUTH AND CENTRAL AMERICA ANTICOAGULANT REVERSAL DRUG MARKET SEGMENTATION
By Product
By Distribution Channel
By Country
Companies Mentioned
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 29.8 Million |
| Market Size by 2027 | US$ 63.1 Million |
| CAGR (2019 - 2027) | 10.5% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South and Central America Anticoagulant Reversal Drug Market is valued at US$ 29.8 Million in 2019, it is projected to reach US$ 63.1 Million by 2027.
As per our report South and Central America Anticoagulant Reversal Drug Market, the market size is valued at US$ 29.8 Million in 2019, projecting it to reach US$ 63.1 Million by 2027. This translates to a CAGR of approximately 10.5% during the forecast period.
The South and Central America Anticoagulant Reversal Drug Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Anticoagulant Reversal Drug Market report:
The South and Central America Anticoagulant Reversal Drug Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Anticoagulant Reversal Drug Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Anticoagulant Reversal Drug Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South and Central America Anticoagulant Reversal Drug Market
